Title for MeetingAbstracts
Alphabetical listing of titles
Pharmacoeconomics of hip arthroplasty in the Lazio region: a pilot study with data from a regional registry.
Pharmacoeconomics of Liposomal Amphotericin B Versus Amphotericin B Lipid Complex in the Empirical Treatment of Persistently Febrile Neutropenic Patients.
Pharmacoepidemiological Approach of the Impact of b-Lactam use on the Risk of Acute Otitis (AO) in Children.
Pharmacoepidemiology and drug interactions in ambulatory HIV-positive patients with less than 100 CD4+ cells.
Pharmacoepidemiology as a tool for health technology assessment.
Pharmacogenetics and HIV-1 Infection - CBM-SDI-4321 Study.
Pharmacogenetics of Antiretrovirals.
Pharmacogenomic Signatures of the Anti-Mycotic Terbinafine.
Pharmacokinetic (PK) and Pharmacodynamic (PD) Evaluation of Methadone (MD) Enantiomers Following Co-Administration with Amprenavir (APV) in Opioid-Dependent Subjects.
Pharmacokinetic (PK) and pharmacodynamic (PD) interactions between nelfinavir and methadone.
Pharmacokinetic (PK) and Pharmacodynamic (PD) Profile of High Dose Extended Interval Piperacillin/Tazobactam (P/T).
Pharmacokinetic (PK) comparison of two indinavir (IDV)/ritonavir (RTV) regimens in salvage therapy.
Pharmacokinetic (PK) Drug Interaction with Saquinavir Soft Gelatin Capsule.
Pharmacokinetic (PK) Drug-Drug Interaction between Capravirine (CPV), Lopinavir/Ritonavir (LPV/RTV), and Tenofovir (TDF) in Healthy Volunteers.
Pharmacokinetic (PK) drug-interaction between amprenavir (APV) and ritonavir (RTV) in HIV-seronegative subjects after multiple, oral dosing.
Pharmacokinetic (PK) Effect of Rifabutin (RIF) on Atazanavir (ATV) with and without Ritonavir (RTV) in Healthy Subjects.
Pharmacokinetic (PK) Evaluation of Nelfinavir (NFV) in Combination with Nevirapine (NVP) or Ritonavir (RTV) in HIV-Infected Children - PACTG 403.
Pharmacokinetic (PK) evaluation of saquinavir soft gel capsules (SQV)/ritonavir (RTV) or sqv/nelfinavir (NFV) in combination with delavirdine (DLV) and/or adefovir dipivoxil (ADV) - - ACTG 359.
Pharmacokinetic (PK) interaction between 141W94 and rifabutin (RFB) and rifampin (RFP) after multiple-dose administration.
Pharmacokinetic (pk) interaction between lopinavir/ritonavir (LPV/r) and amprenavir (APV) does not affect virologic response to the combination of LPV/r, APV and RTV in HIV-infected patients (pts) with multiple treatment failure (Puzzle 1-ANRS104 Study).
Pharmacokinetic (PK) Interaction between Nevirapine (NVP) and Indinavir (IDV) in ANRS 081 Trial.
Pharmacokinetic (PK) Interaction between Nevirapine (NVP) and Rifabutin (RFB).
Pharmacokinetic (PK) interaction between nevirapine (NVP) and rifampin (RMP).
Pharmacokinetic (PK) Interaction between the HIV Protease Inhibitors Tipranavir and Ritonavir.
Pharmacokinetic (PK) interaction of ag1549, a novel nonnucleoside reverse transcriptase inhibitor (nnrti), with protease inhibitors (PI).
Pharmacokinetic (PK) interaction studies in healthy volunteers with efavirenz (EFV) and the macrolide antibiotics, azithromycin (AZM) and clarithromycin (CLR).
Pharmacokinetic (PK) interactions between ritonavir (RTV) and amprenavir (APV) in healthy volunteers.
Pharmacokinetic (PK) Interactions between the HIV Protease Inhibitors Ritonavir (RTV) and Saquinavir (SQV) and VIAGRA[[TM] ](Sildenafil Citrate).
Pharmacokinetic Analysis of Succinate-proline Hydroxymates as Peptide Deformylase Inhibitors.
Pharmacokinetic analysis of the enhanced distribution of Zidovudine into rabbit cerebrospinal fluid caused by probenecid.